India, Feb. 14 -- Glenmark Pharmaceuticals on Friday said its subsidiary has launched generic medication to treat glaucoma in the US market.
Glenmark Pharmaceuticals Inc, USA has launched Latanoprost ophthalmic solution, 0.005% (0.05 mg/mL) in the market, the Mumbai-based drug maker said in a statement.
The company's product is therapeutically equivalent to Upjohn US LLC's reference listed drug, Xalatan Ophthalmic Solution, it added.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....